Baumal Caroline

Apellis Pharmaceuticals, Inc. · Chief Medical Officer

Baumal Caroline is listed in public filings as officer: Chief Medical Officer. This Baumal Caroline insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Apellis Pharmaceuticals, Inc. (APLS). Investors use Baumal Caroline's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Apellis Pharmaceuticals, Inc.APLS$049k sharesOtherMay 14, 2026$2.5M49k shares$50.28--
Apellis Pharmaceuticals, Inc.APLS$037k sharesOtherMay 14, 2026$2.5M37k shares$66.30--
Apellis Pharmaceuticals, Inc.APLS$082.5k sharesOtherMay 14, 2026$1.6M82.5k shares$19.39--
Apellis Pharmaceuticals, Inc.APLS$086.5k sharesOtherMay 14, 2026$986.5k shares$0.0001--
Apellis Pharmaceuticals, Inc.APLS--29.7k sharesOtherMay 14, 2026Disclosure amount unavailable29.7k shares----
Apellis Pharmaceuticals, Inc.APLS--26.4k sharesGrant / ExerciseMay 14, 2026Disclosure amount unavailable26.4k shares----
Apellis Pharmaceuticals, Inc.APLS--41.3k sharesGrant / ExerciseMay 14, 2026Disclosure amount unavailable41.3k shares----

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Apellis Pharmaceuticals, Inc.APLS--86.5k sharesGrant / ExerciseApr 29, 2026Disclosure amount unavailable900 shares----
Apellis Pharmaceuticals, Inc.APLS$1.9M86.5k sharesSellJan 22, 2026$60.9K2.8k shares$21.77--
Apellis Pharmaceuticals, Inc.APLS$1.8M89.3k sharesSellJan 20, 2026$37.3K1.9k shares$19.79--
Apellis Pharmaceuticals, Inc.APLS$2.3M91.2k sharesSellJan 5, 2026$77.1K3k shares$25.53--
Apellis Pharmaceuticals, Inc.APLS$1.6M82.5k sharesGrant / ExerciseJun 9, 2025$1.6M82.5k shares$19.39--